ClinicalTrials.gg
Drug

BMS201038 clinical trials

Also written lomitapide, AEGR-733, Juxtapid and BMS-201038.

studies test it
15
open now
0
in phase 3
5
first study started
2003

How each study uses BMS201038 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
21 Dec 2012 · JUXTAPID · NDA 203858 (FDA, Drugs@FDA)
European Union
31 Jul 2013 · Lojuxta · EMEA/H/C/002578 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Juxtapid, Lojuxta
2

Brand

Juxtapid
4

Development codes

AEGR-733
5
BMS-201038
3

Other names

lomitapide
11

Studies by the year they started

15 studies that test it; most in 2007 (3)

Studies that test BMS201038, by start year
YearStudies
20031
20061
20073
20081
20091
20121
20132
20143
20161
20201

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
5
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 15 · Other 0

Aegerion Pharmaceuticals, Inc. (14) · Amryt Pharma (1)

Often tested with

Tested in the same studies.

Atorvastatin (2) · Norgestimate (1) · Ezetimibe (1)

Studies

Open first, then newest update. How each study uses BMS201038 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 15

Codes

What other systems call BMS201038 · ClinicalTrials.gg INT004528

Also registered as lomitapide (UNII 82KUB0583F · RxNorm 1364479) and lomitapide mesylate (UNII X4S83CP54E · RxNorm 1364478).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.